Merck & Company (MRK)

Merck & Company Stock Price & Analysis


MRK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$69.08 - $107.50
Previous Close$107.5
Average Volume (3M)8.94M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$11.25B
Total Debt (Recent Filing)$30.42B
Price to Earnings (P/E)17.9
Next EarningsFeb 02, 2023
Dividend Yield2.76 (2.57%)
EPS (TTM)6.01
Shares Outstanding2,535,395,974
Standard Deviation0.06
10 Day Avg. Volume8,525,644
30 Day Avg. Volume8,939,211
Price to Book (P/B)141.22
Price to Sales (P/S)4.62
Price to Cash Flow (P/CF)13.90
P/FCF Ratio-89.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside1.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Merck & Company’s price range in the past 12 months?
Merck & Company lowest stock price was $69.08 and its highest was $107.50 in the past 12 months.
    What is Merck & Company’s market cap?
    Currently, no data Available
    When is Merck & Company’s upcoming earnings report date?
    Merck & Company’s upcoming earnings report date is Feb 02, 2023 which is in 66 days.
      How were Merck & Company’s earnings last quarter?
      Merck & Company released its earnings results on Oct 27, 2022. The company reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.705 by $0.145.
        Is Merck & Company overvalued?
        According to Wall Street analysts Merck & Company’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Merck & Company pay dividends?
          Merck & Company pays a Quarterly dividend of $0.69 which represents an annual dividend yield of 2.57%. Merck & Company’s last Quarterly dividend payment was on Oct 07, 2022. Merck & Company’s upcoming ex-dividend date is Sep 14, 2022
            What is Merck & Company’s EPS estimate?
            Merck & Company’s EPS estimate is $1.53.
              How many shares outstanding does Merck & Company have?
              Merck & Company has 2,535,396,000 shares outstanding.
                What happened to Merck & Company’s price movement after its last earnings report?
                Merck & Company reported an EPS of $1.85 in its last earnings report, beating expectations of $1.705. Following the earnings report the stock price went up 1.351%.
                  Which hedge fund is a major shareholder of Merck & Company?
                  Among the largest hedge funds holding Merck & Company’s share is Fisher Asset Management LLC. It holds Merck & Company’s shares valued at 1B.


                    Merck & Company Stock Smart Score

                    The Merck & Company stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Merck & Company

                    Merck & Co., Inc. develops pharmaceutical and vaccine products. It also offers healthcare solutions and vaccines addressing animal health. The company was founded in 1891 and is headquartered in Kenilworth, NJ.


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Johnson & Johnson
                    Eli Lilly & Co
                    Bristol Myers

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis